Inspire Medical Systems (INSP)
(Real Time Quote from BATS)
$243.84 USD
+6.39 (2.69%)
Updated Apr 29, 2024 03:57 PM ET
1-Strong Buy of 5 1
D Value A Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
INSP 243.84 +6.39(2.69%)
Will INSP be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for INSP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INSP
How You Should Play Hologic (HOLX) Ahead of Q2 Earnings
Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Rise
INSP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Edwards Lifesciences (EW) Q1 Earnings Top, 2024 Sales View Up
Should Lifeward (LFWD) be in Your Portfolio Ahead of Q1 Earnings?
ResMed (RMD) Q3 Earnings Beat Estimates, Margins Expand
Other News for INSP
Inspire Medical Systems Larger Than S&P 500 Component Comerica
Analysts Have Conflicting Sentiments on These Healthcare Companies: Inspire Medical Systems (INSP) and AdaptHealth (AHCO)
The Latest Analyst Ratings For Inspire Medical Systems
Analysts Are Bullish on These Healthcare Stocks: Gilead Sciences (GILD), Biogen (BIIB)
RBC Capital starts Inspire Medical at outperform, cites first-mover status